Legend Biotech Corp Key Management Personnel Compensation
Legend Biotech Corp (LEGN) reported Key Management Personnel Compensation of $18.30 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensation · last filed 2026-03-10
- Legend Biotech Corp key management personnel compensation for the quarter ending 2023-12-31 was $3.63M, a 144.74% increase year-over-year.
- Legend Biotech Corp key management personnel compensation for the quarter ending 2023-09-30 was $2.48M, a 37.83% increase year-over-year.
- Legend Biotech Corp key management personnel compensation for the quarter ending 2022-12-31 was $1.48M.
- Legend Biotech Corp key management personnel compensation for the quarter ending 2022-09-30 was $1.80M.
| Period end | Key Management Personnel Compensation 3 month | Key Management Personnel Compensation 6 month | Key Management Personnel Compensation 9 month | Key Management Personnel Compensation 12 month | Key Management Personnel Compensation 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $18.30M 20-F · filed 2026-03-10 | ||||
| 2024-12-31 | $25.80M 20-F · filed 2026-03-10 | $25.83M 20-F · filed 2025-03-11 | |||
| 2023-12-31 | $3.63M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $6.11M derived: sum of 2 quarters · filed 2026-03-10 | $10.70M 20-F · filed 2026-03-10 | $10.73M 20-F · filed 2024-03-19 | |
| 2023-09-30 | $2.48M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $7.07M 6-K · filed 2023-11-20 | |||
| 2023-06-30 | $4.59M 6-K · filed 2023-08-15 | ||||
| 2022-12-31 | $1.48M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $3.28M derived: sum of 2 quarters · filed 2025-03-11 | $5.75M 20-F · filed 2025-03-11 | ||
| 2022-09-30 | $1.80M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $4.27M 6-K · filed 2023-11-20 | |||
| 2022-06-30 | $2.47M 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | $4.85M 20-F · filed 2024-03-19 | ||||
| 2021-06-30 | $2.13M 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | $3.04M 20-F · filed 2023-03-30 | ||||
| 2020-06-30 | $1.22M 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | $1.63M 20-F/A · filed 2023-02-17 | ||||
| 2018-12-31 | $902.00K 20-F · filed 2021-04-02 |